ETF Holdings Breakdown of MNMD

News associated with MNMD

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned an average rating of “Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month […] - 2025-06-09 05:34:47

Reviewing Mind Medicine (MindMed) (NASDAQ:MNMD) and PacificHealth Laboratories (OTCMKTS:PHLI)

Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) and PacificHealth Laboratories (OTCMKTS:PHLI – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of […] - 2025-06-06 05:55:01

BNP Paribas Financial Markets Invests $74,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

BNP Paribas Financial Markets purchased a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 10,631 shares of the company’s stock, valued at approximately $74,000. Several other institutional investors have also modified their holdings of the company. Ameriprise Financial Inc. bought […] - 2025-06-02 07:44:55

Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Northern Trust Corp raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 684,836 shares of the company’s stock after purchasing an additional 76,559 shares during the period. […] - 2025-05-22 07:20:53

Raymond James Financial Inc. Acquires Shares of 16,004 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Raymond James Financial Inc. bought a new position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 16,004 shares of the company’s stock, valued at approximately $111,000. Several other institutional investors and hedge funds also recently bought and sold […] - 2025-05-14 07:22:48

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 61.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 39,974 shares of the company’s stock after purchasing an additional 15,269 shares during the period. Wells Fargo & Company MN’s […] - 2025-05-07 07:18:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Legal & General Group Plc

Legal & General Group Plc cut its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 8.8% during the fourth quarter, HoldingsChannel reports. The fund owned 58,437 shares of the company’s stock after selling 5,639 shares during the period. Legal & General Group Plc’s holdings in Mind Medicine (MindMed) were worth $407,000 at […] - 2025-04-30 07:54:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.11 Consensus Target Price from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 12-month […] - 2025-04-23 05:30:49

Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,121 shares of the company’s stock after buying an additional 10,338 shares during the quarter. […] - 2025-03-24 07:08:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-04 06:22:57

Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average […] - 2025-02-07 06:32:50

China Universal Asset Management Co. Ltd. Buys Shares of 15,549 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

China Universal Asset Management Co. Ltd. bought a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 15,549 shares of the company’s stock, valued at approximately $108,000. A number of other hedge funds have also made changes to their positions in […] - 2025-02-04 09:46:56

MNMD institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	53,443	USD 360,206
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	3,163	USD 21,319
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	37,056	USD 249,757
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	37,056	USD 249,757
Total =		130,718	USD 881,039

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer